Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus

Linnebjerg, H; Lam, ECQ; Zhang, X; Seger, ME; Coutant, D; Chua, LY; Kapitza, C; Heise, T

Linnebjerg, H (reprint author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.

DIABETES OBESITY & METABOLISM, 2017; 19 (1): 33

Abstract

Aims: LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products manufactured by distinct processes, but with identical amino acid sequence......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索